Zhejiang Huahai Pharmaceutical Co., Ltd.

2 in Phase 3

Quick facts

Phase 3 pipeline

Duloxetine Hydrochloride Enteric Capsules · Psychiatry / Pain Management
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases levels of serotonin and norepinephrine in the central nervous system by blocking their reuptake at the presynaptic membrane.
Levomilnacipran Hydrochloride Extended-Release Capsules · Psychiatry / Neurology
Levomilnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases levels of serotonin and norepinephrine in the brain by blocking their reuptake at the neuronal synapse.

Phase 2 pipeline

Hypidone Hydrochloride tablets

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Zhejiang Huahai Pharmaceutical Co., Ltd.

What is Zhejiang Huahai Pharmaceutical Co., Ltd.'s pipeline?

Zhejiang Huahai Pharmaceutical Co., Ltd. has 2 drugs in Phase 3, 1 in Phase 2, 0 in Phase 1. Late-stage candidates include Duloxetine Hydrochloride Enteric Capsules, Levomilnacipran Hydrochloride Extended-Release Capsules.

Sector hub: All tracked pharma companies